NLGN3 and central nervous system cancer: This neuronal activity can trigger the shedding of the synaptic protein Neuroligin-3 (NLGN3), which activates oncogenic signaling cascades and drives synaptic gene expression in glioma cells, potentially contributing to epileptic activity.